You searched for "information"
Life in the glaucoma laboratory
When people ask me what life in the laboratory is really like, I often pause. On one hand, it is the romantic notion of pushing back the boundaries of science with the daily rhythm of experiments, data and easily obtained...I am interested in making my ophthalmology practice sustainable, but where do I start?
I have yet to meet an ophthalmologist who does not care about a sustainable future for our planet, but the challenge lies in knowing where and how to start. Quite often, as individuals, we see ourselves less empowered when it...Heidelberg Engineering supplies free protective breath shields
Heidelberg Engineering has announced that it is shipping protective breath shields free of charge to SPECTRALIS owners in the UK.
Features of childhood cases of sixth nerve palsy
Based on limited information available for cranial nerve palsies in children, the authors aimed to collect data on new onset paediatric sixth nerve palsies in a UK population. This was a retrospective study over 10 years for children aged <18...Another plant-based remedy for the eye?
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Another plant-based remedy for the eye? What do the nicknames Mary Jane, tea, and 420 all...
Long-term results of cross-linking treatment for keratoconus
The authors report on the long-term outcomes in a prospective case series of patients with keratoconus undergoing corneal collagen cross-linking (CXL) treatment. Thirty-two patients (40 eyes; mean age 22.5+/-5.5 years) with Grade I, II and III progressive keratoconus were recruited...Orbis and FundamentalVR to talk at 100% Optical
The health care technology company teams up with the global non-profit to showcase how simulation, telemedicine and virtual reality (VR) are changing the landscape of cataract surgery education.Gene therapy for inherited retinal disease: the Manchester Ocular Gene Therapy Group MDT service
The authors describe the process set up in Manchester for the optimum delivery and assessment of a new gene therapy treatment for patients with RPE65 IRD. Inherited retinal dystrophies (IRDs) are the second commonest cause of severe visual impairment in...Introducing: iGLEAMS-3
30 September (Colchester FirstSite) – 1 October (Colchester ICENI Centre)
